Bunzl PLC Issue of Debt (5402D)

TIDMBNZL

RNS Number : 5402D

Bunzl PLC

29 October 2020

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

29 October 2020

BUNZL FINANCE PLC

PUBLICATION OF PRICING SUPPLEMENT IN RELATION TO THE ISSUE OF GBP400,000,000 1.5 PER CENT. SENIOR UNSECURED NOTES DUE 2030 (THE "NOTES") UNDER THE GBP1,000,000,000 EURO MEDIUM TERM NOTE PROGRAMME ESTABLISHED BY BUNZL FINANCE PLC (THE "EMTN PROGRAMME")

Bunzl Finance plc (the "Issuer") has today published a pricing supplement dated 28 October 2020 setting out details of the Notes (the "Pricing Supplement"). The Pricing Supplement should be read in conjunction with the admission particulars published on 21 July 2020, including all documents incorporated thereto by reference (together, the "Admission Particulars").

To view the Pricing Supplement, please paste the following URL into the address bar of your browser:

https://www.bunzl.com/investors/debt-investors.aspx

For further information please contact:

Bunzl Finance plc

York House

45 Seymour Street

London

W1H 7JT

United Kingdom

Email: [e-mail]

Attention: Suzanne Jefferies

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement and the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and are not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Pricing Supplement and/or the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Pricing Supplement and the Admission Particulars do not constitute an offer of securities for sale in the United States. The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the Notes, see the "Subscription and Sale" section in the Admission Particulars.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IODKKFBNFBDDBKB

(END) Dow Jones Newswires

October 29, 2020 03:00 ET (07:00 GMT)